Published in Cancer Weekly, August 22nd, 2006
Study 1: The risk of melanoma in patients with congenital melanocytic nevi (CMN) was reviewed.
According to researchers from Germany, "The risk of malignant melanoma in CMN is a matter of controversial and ongoing debate. The purpose of this systematic review is to provide a careful and detailed summary of the published data, including several recently published studies."
"Articles on CMN (n=1424) were retrieved from Medline, 1966-October 2005," explained S. Krengel and colleagues, Medical University of Lubeck. "Case reports and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2006-08-22)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.